The latest headlines across every section, pulled from official and open-access sources.
On July 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity Inc.) in combination with fulvestrant, with or without palbociclib, for adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic bre
FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors
The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard-of-care for patients with breast cancer.
Every year, the BIO International Convention brings together more than 20,000 leaders from across the global life sciences ecosystem.
Terms of reference for Ministerial Group for Digital Inclusion.
Summary of minutes of the meetings for the Ministerial Group for Digital Inclusion.
Certain delivery systems that are used to insert a pulmonary valve have an increased risk of distal tip detachment, the company said. The valve itself is not affected by the recall.
A report setting out how the Department of Health and Social Care (DHSC) has responded to its equality duties.
How to use the procedure for medicines licensing applications.
After pausing a controversial policy to publicly release drug rejection letters in April, the FDA today confirmed that the pause has been lifted and that more documents will be coming down the line.
Matching the right patient to the right therapy now requires understanding what’s driving the apnea, not just how often it occurs. Closing that gap means rethinking what sleep apnea testing identifies and where it happens. The post Why the Next Era of Sleep Medicine Depends on Better Diagnostics appeared first on MedCity News .
It usually tracks some version of value delivered, where more customers lead to more usage and more revenue. However, in healthcare, the blind pursuit of revenue can cause real harm. The post Revenue Is a Misleading KPI in Healthcare appeared first on MedCity News .
This privacy notice describes how we collect and use your personal information, in accordance with the Data Protection Act and the General Data Protection Regulation.
HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.
Biogen leaders took to an investor call today to defend the phase 2 readout of the company’s anti-tau Alzheimer’s disease candidate, which, despite slowing cognitive decline on par with approved medicines, sparked a significant stock slip.
Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
In this interview, W. Douglas Weaver MD, MACC and Deepak Bhakta, MD, MBA, FACC discuss managing subclinical AFib detected by devices, ambulatory monitors and wearables.
The PBM reform efforts are directional, not temporary. Meeting these expectations requires automated systems that can reconstruct claim logic on demand and provide real-time alignment between pricing, rebates and financial outputs. The post Pharmacy Benefit Operations Infrastructure Must Rise to Regulatory Reform Standards appeared first on MedCity News .
List of residential further education settings whose students may be eligible for the one-off MenB vaccination programme.
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
The 2026 Care of the Athletic Heart was a 1-day preconference held in advance of the American College of Cardiology Annual Scientific Session. The session, hosted by Dr. Jeffrey Hsu, welcomed guests from over 14 countries and aimed to deliver focused, practical updates in sports cardiology, while providing education and insight into this rapidly evolving field.
Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Eli Lilly And Co
Original new drug approval. powder, intravenous. Sponsor: Celcuity
Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Eli Lilly And Co